Impairment from Declines in the Fair Value of Investment Securities
First written in FY2016. 3 of 8 entries say "Materialised", first in FY2022-Q1. Latest entry: FY2023-Q3.
The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.
28 other companies' latest entry also says "Restated".
- FY2023-Q3RestatedAnnual report
「Gain on sale of investment securities — ¥32.561 million Valuation loss on investment securities ¥83.741 million —」
No valuation loss on investment securities was recorded in the third quarter of the current consolidated cumulative period, while a gain on the sale of investment securities of ¥32.561 million was recorded. As in the previous quarter, no valuation loss resulting from a decline in market value occurred. - FY2023-Q2MitigatedAnnual report
「Gain on sale of investment securities — ¥32.548 million Valuation loss on investment securities ¥83.741 million —」
No valuation loss on investment securities was recorded in the second quarter of the current consolidated cumulative period, while a gain on the sale of investment securities of ¥32.548 million was recorded. No loss resulting from a decline in the market value of investment securities occurred compared with the previous fiscal year. - FY2022MaterialisedAnnual report
「During the current consolidated fiscal year, impairment of marketable securities totaling ¥90.973 million was recognized, consisting of ¥90.973 million for shares classified as other securities.」
Impairment of investment securities totaling ¥90.973 million was recognized, and the loss resulting from the decline in market value was reflected in full-year results. - FY2022-Q2MaterialisedAnnual report
「Valuation loss on investment securities — ¥83.741 million」
A valuation loss on investment securities of ¥83.741 million was recorded as an extraordinary loss in the second quarter of the current consolidated cumulative period, and the loss resulting from the decline in the market value of investment securities was reflected in reported results. - FY2022-Q1MaterialisedAnnual report
「Valuation loss on investment securities — ¥83.741 million」
A valuation loss on investment securities of ¥83.741 million was recorded as an extraordinary loss in the first quarter of the current consolidated cumulative period, and the loss resulting from the decline in the market value of investment securities was reflected in reported results. - FY2021RestatedAnnual report
「No securities were subject to impairment in either the previous consolidated fiscal year or the current consolidated fiscal year.」
The disclosure reconfirms that no impairment of marketable securities occurred in the current fiscal year either. - FY2020MitigatedAnnual report
「No securities were impaired during the consolidated fiscal year.」
In the previous fiscal year, a valuation loss on marketable securities of ¥22.855 million was recorded, but no impairment was recognized in the current fiscal year. - FY2016First statedAnnual report
「Because listed shares are subject to market price volatility risk, impairment is recognized if their market value at the consolidated fiscal year-end has declined by 50% or more from acquisition cost. If their market value at the consolidated fiscal year-end has declined by 30% or more but less than 50% from acquisition cost, the likelihood of recovery is assessed based on reasonable criteria, and impairment is recognized except for securities judged likely to recover.」
The disclosure specifies the impairment recognition criteria for marketable securities using specific decline percentages.